Fagerberg B, Lindstedt G, Berglund G
Department of Medicine, Gothenburg University, Sahlgren's Hospital, Sweden.
J Intern Med. 1993 Jun;233(6):477-84. doi: 10.1111/j.1365-2796.1993.tb01002.x.
To examine the relationships between alcohol intake, obesity, plasma insulin concentration and serum activities of three liver enzymes in obese men with mild hypertension.
A 6-week run-in period followed by randomization to either diet treatment or antihypertensive drug treatment, lasting for 1 year. Alcohol intake was estimated using questionnaires. Plasma insulin concentration, serum activities of gamma-glutamyl transferase, and aspartate and alanine aminotransferase, respectively, were measured at entry and after 1 year.
Out-patient clinic, city hospital.
Sixty-four men aged 40-69 years with a body mass index > or = 26 kg m-1 and with mild untreated hypertension. Exclusion criteria were alcoholism and diabetes mellitus. Sixty-one patients completed the study.
Dietary treatment was based upon weight reduction and recommendations about a low alcohol intake. Drug treatment used a stepped-care approach with atenolol as the first-choice drug.
Serum activities of the liver enzymes, body weight, body mass index, alcohol intake, plasma insulin concentration.
Body weight decreased by 7.8 kg in the diet group and increased by 1.0 kg in the drug-treated group. Alcohol intake did not differ between the groups before or after 1 year. Serum gamma-glutamyl transferase activity correlated with alcohol consumption; it showed no significant change after weight loss. At entry, serum activities of aspartate and alanine aminotransferases correlated to plasma insulin concentration independent of body mass index. Weight reduction significantly lowered serum activities of these liver enzymes as well as plasma insulin concentrations and normalized elevated serum activity of alanine aminotransferase in a majority of the cases.
Alcohol intake was an important determinant for elevated serum gamma-glutamyl transferase activity. The degree of obesity was a contributing factor for elevations of serum alanine aminotransferase activity. We speculate that insulin may play a role in this relationship.
研究轻度高血压肥胖男性的酒精摄入量、肥胖、血浆胰岛素浓度与三种肝酶血清活性之间的关系。
为期6周的导入期,随后随机分为饮食治疗组或抗高血压药物治疗组,持续1年。通过问卷调查评估酒精摄入量。在入组时和1年后分别测量血浆胰岛素浓度、γ-谷氨酰转移酶、天冬氨酸氨基转移酶和丙氨酸氨基转移酶的血清活性。
城市医院门诊。
64名年龄在40 - 69岁之间、体重指数≥26 kg/m²且患有未经治疗的轻度高血压的男性。排除标准为酗酒和糖尿病。61名患者完成了研究。
饮食治疗基于减重和低酒精摄入建议。药物治疗采用阶梯式治疗方法,以阿替洛尔为首选药物。
肝酶血清活性、体重、体重指数、酒精摄入量、血浆胰岛素浓度。
饮食组体重下降7.8 kg,药物治疗组体重增加1.0 kg。两组在1年前和1年后的酒精摄入量无差异。血清γ-谷氨酰转移酶活性与酒精消耗量相关;体重减轻后无显著变化。入组时,天冬氨酸和丙氨酸氨基转移酶的血清活性与血浆胰岛素浓度相关,与体重指数无关。体重减轻显著降低了这些肝酶的血清活性以及血浆胰岛素浓度,并使大多数病例中升高的丙氨酸氨基转移酶血清活性恢复正常。
酒精摄入量是血清γ-谷氨酰转移酶活性升高的重要决定因素。肥胖程度是血清丙氨酸氨基转移酶活性升高的一个促成因素。我们推测胰岛素可能在此关系中起作用。